Epibiotech Co., Ltd.

XKON:A446440 Stock Report

Market Cap: ₩23.7b

Epibiotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of A446440?
Owner TypeNumber of SharesOwnership Percentage
Institutions49,1902.14%
Private Companies160,0006.96%
General Public547,26623.8%
VC/PE Firms698,30030.4%
Individual Insiders842,74836.7%

Dilution of Shares: A446440 only recently listed within the past 12 months


Top Shareholders

Top 6 shareholders own 76.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.7%
Jonghyuk Sung
842,748₩8.7b1.2%no data
10.9%
Korea Investment Partners Co. Ltd.
251,256₩2.6b-34.2%1.28%
9.89%
E&Investment, Inc.
227,300₩2.3b-26.5%52.6%
9.56%
Woori Venture Partners Co., Ltd
219,744₩2.3b-24.2%4.32%
6.96%
Yonsei University Technology Holdings Inc.
160,000₩1.6b0%no data
2.14%
IMM Investment, Corp.
49,190₩506.7m-69.1%1.71%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.